Simon Buckingham - Creso Pharma Consultant
| COPHFDelisted Stock | USD 0.12 0.00 0.00% |
Insider
Simon Buckingham is Consultant of Creso Pharma Limited
| Age | 61 |
| Phone | 61 8 9389 3180 |
| Web | https://www.cresopharma.com |
Creso Pharma Management Efficiency
The company has return on total asset (ROA) of (0.3818) % which means that it has lost $0.3818 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.6678) %, meaning that it generated substantial loss on money invested by shareholders. Creso Pharma's management efficiency ratios could be used to measure how well Creso Pharma manages its routine affairs as well as how well it operates its assets and liabilities.Creso Pharma Limited has accumulated 3.26 M in total debt with debt to equity ratio (D/E) of 0.24, which may suggest the company is not taking enough advantage from borrowing. Creso Pharma Limited has a current ratio of 2.63, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Creso Pharma until it has trouble settling it off, either with new capital or with free cash flow. So, Creso Pharma's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Creso Pharma Limited sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Creso to invest in growth at high rates of return. When we think about Creso Pharma's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 1 records | INSIDER Age | ||
| Patricia Colvin | Bionoid Pharma | N/A | |
Management Performance
| Return On Equity | -0.67 | |||
| Return On Asset | -0.38 |
Creso Pharma Limited Leadership Team
Elected by the shareholders, the Creso Pharma's board of directors comprises two types of representatives: Creso Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Creso. The board's role is to monitor Creso Pharma's management team and ensure that shareholders' interests are well served. Creso Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Creso Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Christopher Grundy, Chief Officer | ||
| Simon Buckingham, Consultant | ||
| H Walker, Strategic Committee | ||
| MA MD, CoFounder Director | ||
| AICD DMgt, Ex Chairman | ||
| Gian Trepp, Commercial Director | ||
| ACIS ACIS, Joint Sec | ||
| CPA GAICD, Joint Sec | ||
| William BCom, MD CEO | ||
| Jodi Scott, Ex Operations |
Creso Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Creso Pharma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.67 | |||
| Return On Asset | -0.38 | |||
| Profit Margin | (2.41) % | |||
| Operating Margin | (2.39) % | |||
| Current Valuation | 24.06 M | |||
| Shares Outstanding | 2 B | |||
| Shares Owned By Insiders | 26.99 % | |||
| Price To Book | 0.36 X | |||
| Price To Sales | 4.68 X | |||
| Revenue | 6.22 M |
Currently Active Assets on Macroaxis
| NVDA | NVIDIA | |
| CRESY | Cresud SACIF y | |
| GOOG | Alphabet Inc Class C | |
| FMC | FMC Corporation | |
| XYF | X Financial Class |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in Creso Pink Sheet
If you are still planning to invest in Creso Pharma Limited check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Creso Pharma's history and understand the potential risks before investing.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |